{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T06:16:36Z","timestamp":1738217796292,"version":"3.34.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.msard.2024.106227","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:31:52Z","timestamp":1733877112000},"page":"106227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Biomarkers in patients with autoimmune optic neuritis not associated with multiple sclerosis: Demographic, clinical and prognostic features"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-7276","authenticated-orcid":false,"given":"H\u00fcseyin Nezih","family":"\u00d6zdemir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mine","family":"Top\u00e7uo\u011flu Karako\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Figen","family":"G\u00f6k\u00e7ay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ne\u015fe","family":"\u00c7elebisoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.msard.2024.106227_bib0001","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.survophthal.2019.06.001","article-title":"Critical review: typical and atypical optic neuritis","volume":"64","author":"Abel","year":"2019","journal-title":"Surv. Ophthalmol."},{"issue":"9","key":"10.1016\/j.msard.2024.106227_bib0002","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group","volume":"326","author":"Beck","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.msard.2024.106227_bib0003","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0161-6420(94)31103-1","article-title":"The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial","volume":"101","author":"Beck","year":"1994","journal-title":"Ophthalmology."},{"issue":"1","key":"10.1016\/j.msard.2024.106227_bib0004","first-page":"10","article-title":"Optic neuritis: current challenges in diagnosis and management","volume":"36","author":"Benard-Seguin","year":"2023","journal-title":"Curr. Opin. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.106227_bib0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.survophthal.2019.08.001","article-title":"Optic neuritis in the era of biomarkers","volume":"65","author":"Chen","year":"2020","journal-title":"Surv. Ophthalmol."},{"issue":"13","key":"10.1016\/j.msard.2024.106227_bib0006","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1177\/1352458518800815","article-title":"Age is a critical determinant in recovery from multiple sclerosis relapses","volume":"25","author":"Conway","year":"2019","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2024.106227_bib0007","doi-asserted-by":"crossref","first-page":"14603","DOI":"10.1038\/s41598-021-93976-1","article-title":"Clinical characteristics of optic neuritis phenotypes in a 3-year follow-up Chinese cohort","volume":"11","author":"Feng","year":"2021","journal-title":"Sci Rep."},{"issue":"5","key":"10.1016\/j.msard.2024.106227_bib0008","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2024.106227_bib0009","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ophtha.2019.04.042","article-title":"Epidemiologic and clinical characteristics of optic neuritis in Japan","volume":"126","author":"Ishikawa","year":"2019","journal-title":"Ophthalmology."},{"issue":"1","key":"10.1016\/j.msard.2024.106227_bib0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius","year":"2020","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"12","key":"10.1016\/j.msard.2024.106227_bib0011","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1038\/s41433-024-03108-y","article-title":"MOG antibody-associated optic neuritis","volume":"38","author":"Jeyakumar","year":"2024","journal-title":"Eye (Lond)"},{"issue":"10","key":"10.1016\/j.msard.2024.106227_bib0012","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ophtha.2018.03.041","article-title":"Aquaporin-4 and myelin oligodendrocyte glycoprotein autoantibody status predict outcome of recurrent optic neuritis","volume":"125","author":"Jitprapaikulsan","year":"2018","journal-title":"Ophthalmology."},{"issue":"5","key":"10.1016\/j.msard.2024.106227_bib0013","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1212\/NXI.0000000000000270","article-title":"Optic neuropathy associated with systemic sarcoidosis","volume":"3","author":"Kidd","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.msard.2024.106227_bib0014","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1007\/s00415-023-11920-x","article-title":"An update on optic neuritis","volume":"270","author":"Kraker","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2024.106227_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104739","article-title":"Clinical characteristics and prognosis of optic neuritis in Taiwan - a hospital-based cohort study","volume":"75","author":"Lin","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2024.106227_bib0016","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1755-3768.2008.01193.x","article-title":"Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review","volume":"87","author":"Lin","year":"2009","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.msard.2024.106227_bib0017","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00415-018-8956-y","article-title":"Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation","volume":"265","author":"Lotan","year":"2018","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2024.106227_bib0018","doi-asserted-by":"crossref","first-page":"e963","DOI":"10.1111\/aos.14659","article-title":"A novel excel sheet conversion tool from Snellen fraction to LogMAR including 'counting fingers', 'hand movement', 'light perception' and 'no light perception' and focused review of literature of low visual acuity reference values","volume":"99","author":"Moussa","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.msard.2024.106227_bib0019","doi-asserted-by":"crossref","first-page":"1360e1364","DOI":"10.1136\/jnnp-2011-300403","article-title":"Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes","volume":"82","author":"Nagaishi","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.msard.2024.106227_bib0020","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","article-title":"Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis","volume":"16","author":"Petzold","year":"2017","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.msard.2024.106227_bib0021","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1474-4422(22)00200-9","article-title":"Diagnosis and classification of optic neuritis","volume":"21","author":"Petzold","year":"2022","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.msard.2024.106227_bib0022","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/bjophthalmol-2013-303119","article-title":"Normal macular structure measured with optical coherence tomography across ethnicity","volume":"98","author":"Pilat","year":"2014","journal-title":"Br. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.msard.2024.106227_bib0023","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2024.106227_bib0024","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00330-014-3358-8","article-title":"Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning\u2013an ultrahigh-field MR pilot study","volume":"25","author":"Sinnecker","year":"2015","journal-title":"Eur. Radiol."},{"issue":"44","key":"10.1016\/j.msard.2024.106227_bib0025","doi-asserted-by":"crossref","first-page":"e5194","DOI":"10.1097\/MD.0000000000005194","article-title":"Optic neuritis as an initial presentation of primary Sj\u00f6gren syndrome: a case report and literature review","volume":"95","author":"Sun","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.msard.2024.106227_bib0026","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"7\u20138","key":"10.1016\/j.msard.2024.106227_bib0027","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/08820538.2020.1866027","article-title":"MRI Characteristics of NMO, MOG and MS Related Optic Neuritis","volume":"35","author":"Winter","year":"2020","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.msard.2024.106227_bib0028","doi-asserted-by":"crossref","unstructured":"Yan R., Mao Y., Zeng H., et al. Collapsin response mediator protein 5-associated optic neuropathy: clinical characteristics, radiologic clues, and outcomes. Front Neurol. 2023;14:1163615. doi: 10.3389\/fneur.2023.1163615. PMID: 37448746; PMCID: PMC10337587.","DOI":"10.3389\/fneur.2023.1163615"},{"issue":"10","key":"10.1016\/j.msard.2024.106227_bib0029","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/bjophthalmol-2017-311177","article-title":"Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients","volume":"102","author":"Zhao","year":"2018","journal-title":"Br. J. Ophthalmol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824008034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824008034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T20:59:50Z","timestamp":1738184390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824008034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":29,"alternative-id":["S2211034824008034"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.106227","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers in patients with autoimmune optic neuritis not associated with multiple sclerosis: Demographic, clinical and prognostic features","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.106227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106227"}}